Article

OptiMedica sells retina, glaucoma assets to Topcon

OptiMedica Corp. is selling its retina and glaucoma assets to Topcon Corp. to focus exclusively on its cataract-related business.

Santa Clara, CA-OptiMedica Corp. is selling its retina and glaucoma assets to Topcon Corp. to focus exclusively on its cataract-related business, including the global market launch of a laser cataract surgery system and cataract-focused research and development.

The company expects to launch its laser cataract surgery system in the United States and in international markets in 2011.

“Topcon has been an outstanding distribution partner for the pattern scan laser photocoagulator [PASCAL] in several major markets, so we are confident that they are ideally suited to advancing [the photocoagulator] in the global marketplace,” said Mark J. Forchette, OptiMedica president and chief executive officer.

Hiroshi Fukuzawa, general manager, eye care business unit, Topcon, said the acquisition is the largest in the company’s medical division.

“Given the aging population and continued growth in diabetic and age-related eye disease, the therapeutic laser market continues to be a major opportunity in ophthalmology,” Fukuzawa said.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
© 2025 MJH Life Sciences

All rights reserved.